About Halozyme
Halozyme Therapeutics is a biotechnology company that focuses on the development and commercialization of innovative therapies for human health. Founded with the vision to enhance the effectiveness of therapies by improving the delivery and absorption of drugs, Halozyme has made significant contributions to the field of therapeutics. Their proprietary product, Hylenex, is an enzyme that facilitates the distribution and absorption of injected drugs, thereby improving patient outcomes.
The company is also well-known for its collaboration with major pharmaceutical companies, leveraging its ENHANZE drug delivery technology to enhance the performance of biologics. With a commitment to research and development, Halozyme continues to explore new treatments for various diseases, solidifying its position in the biotechnology industry as a leader in drug delivery solutions.
FAQs
- When was Halozyme founded?
- Halozyme was founded in 1998.
- Who is the CEO of Halozyme?
- Helen Torley is the CEO.
- What industries or markets does Halozyme operate in?
- Halozyme operates in the following markets: Biotechnology, Drug Delivery Systems, Healthcare, Therapeutics, Biologics, Medical Research, Life Sciences, Healthcare Technology, Collaborative Drug Development, and Pharmaceutical.
- How many employees does Halozyme have?
- Halozyme has 201-500 employees.
- Where does Halozyme have employees?
- Halozyme has employees in Zimbabwe.
- Is Halozyme hiring?
- Yes, Halozyme has 5 open remote jobs.
- Does Halozyme support remote work or working from home?
- Yes, Halozyme is a remote-friendly company.
- Does Halozyme offer a four-day work week?
- No, Halozyme does not offer a four-day work week.
- Is Halozyme transparent about salaries?
- Yes, Halozyme practices salary transparency, often including salary or compensation ranges in their job posts. They provide salary data for 8 roles.
- What is Halozyme's website?
- Halozyme's website is halozyme.com.
Zimbabwe
United States only
